JP2006513978A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006513978A5 JP2006513978A5 JP2004525238A JP2004525238A JP2006513978A5 JP 2006513978 A5 JP2006513978 A5 JP 2006513978A5 JP 2004525238 A JP2004525238 A JP 2004525238A JP 2004525238 A JP2004525238 A JP 2004525238A JP 2006513978 A5 JP2006513978 A5 JP 2006513978A5
- Authority
- JP
- Japan
- Prior art keywords
- gly
- leu
- glu
- gln
- ser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000539 amino acid group Chemical group 0.000 claims description 27
- 108010066381 preproinsulin Proteins 0.000 claims description 16
- 101000976075 Homo sapiens Insulin Proteins 0.000 claims description 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 9
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 claims description 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 7
- 239000004026 insulin derivative Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 3
- 238000000034 method Methods 0.000 claims 11
- 238000004587 chromatography analysis Methods 0.000 claims 5
- 238000011097 chromatography purification Methods 0.000 claims 4
- 108090001061 Insulin Proteins 0.000 claims 2
- 102000004877 Insulin Human genes 0.000 claims 2
- 229940125396 insulin Drugs 0.000 claims 2
- 244000005700 microbiome Species 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 150000001768 cations Chemical class 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 230000007850 degeneration Effects 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 210000003000 inclusion body Anatomy 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10235168A DE10235168A1 (de) | 2002-08-01 | 2002-08-01 | Verfahren zur Reinigung von Preproinsulin |
| PCT/EP2003/007820 WO2004013176A1 (de) | 2002-08-01 | 2003-07-18 | Verfahren zur reinigung von preproinsulin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006513978A JP2006513978A (ja) | 2006-04-27 |
| JP2006513978A5 true JP2006513978A5 (cg-RX-API-DMAC7.html) | 2006-09-14 |
| JP4519646B2 JP4519646B2 (ja) | 2010-08-04 |
Family
ID=30128614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004525238A Expired - Fee Related JP4519646B2 (ja) | 2002-08-01 | 2003-07-18 | プレプロインスリンの精製方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20050080000A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1527097B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4519646B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE384742T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003254375B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0313131A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2493539C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1108046T1 (cg-RX-API-DMAC7.html) |
| DE (2) | DE10235168A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1527097T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2297223T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL166438A (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05001042A (cg-RX-API-DMAC7.html) |
| PT (1) | PT1527097E (cg-RX-API-DMAC7.html) |
| SI (1) | SI1527097T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004013176A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6428771B1 (en) * | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
| ES2395096T3 (es) * | 1999-06-29 | 2013-02-08 | Mannkind Corporation | Purificación y estabilización de agentes farmacéuticos a base de péptidos y proteínas |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| JP4681231B2 (ja) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | 吸入装置 |
| US7338171B2 (en) * | 2003-10-27 | 2008-03-04 | Jen-Chuen Hsieh | Method and apparatus for visual drive control |
| US20050153874A1 (en) * | 2004-01-12 | 2005-07-14 | Mannkind Corporation | Method of reducing serum proinsulin levels in type 2 diabetics |
| EP2106790B1 (en) * | 2004-03-12 | 2012-10-24 | Biodel, Inc. | Rapid acting drug delivery compositions |
| US20080090753A1 (en) | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions |
| ATE486064T1 (de) | 2004-08-20 | 2010-11-15 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diceto-piperazine salts for drug delivery |
| MX373000B (es) | 2005-09-14 | 2020-05-21 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| US20070086952A1 (en) * | 2005-09-29 | 2007-04-19 | Biodel, Inc. | Rapid Acting and Prolonged Acting Inhalable Insulin Preparations |
| US8084420B2 (en) * | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| US7713929B2 (en) | 2006-04-12 | 2010-05-11 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| CN104383546B (zh) | 2006-02-22 | 2021-03-02 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
| WO2007121256A2 (en) * | 2006-04-12 | 2007-10-25 | Biodel, Inc. | Rapid acting and long acting insulin combination formulations |
| WO2009089181A1 (en) * | 2008-01-04 | 2009-07-16 | Blodel, Inc. | Insulin formulations for insulin release as a function of tissue glucose levels |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| MY155524A (en) | 2008-06-13 | 2015-10-30 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
| TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
| PT3228320T (pt) | 2008-10-17 | 2020-03-26 | Sanofi Aventis Deutschland | Combinação de uma insulina e de um agonista do glp-1 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| US9060927B2 (en) * | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
| US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| AU2010259943C1 (en) | 2009-06-12 | 2016-03-03 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| PH12011502708B1 (en) | 2009-07-06 | 2017-11-10 | Sanofi Aventis Deutschland | Insulin preparations containing methionine |
| PL2464655T3 (pl) * | 2009-08-11 | 2017-08-31 | Biocon Limited | Procesy chromatograficzne |
| JP5784622B2 (ja) | 2009-11-03 | 2015-09-24 | マンカインド コーポレ−ション | 吸入活動をシミュレートするための装置及び方法 |
| SG10201500871TA (en) | 2009-11-13 | 2015-04-29 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a glp-1 agonist and methionine |
| JP5832439B2 (ja) | 2009-11-13 | 2015-12-16 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Glp−1アゴニスト、インスリン及びメチオニンを含む薬学的組成物 |
| AU2011202239C1 (en) | 2010-05-19 | 2017-03-16 | Sanofi | Long-acting formulations of insulins |
| RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
| CN103179978A (zh) | 2010-08-30 | 2013-06-26 | 赛诺菲-安万特德国有限公司 | Ave0010用于制造供治疗2型糖尿病用的药物的用途 |
| AU2012213432B2 (en) | 2011-02-01 | 2016-10-13 | Novo Nordisk A/S | Purification of insulin |
| DE102011003944A1 (de) | 2011-02-10 | 2012-08-16 | Oxprotect Gmbh | Detektion und Entfernung von missgefalteten Proteinen/Peptiden |
| MX353285B (es) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Paquete de blister para cartuchos farmaceuticos. |
| CN102219851B (zh) * | 2011-05-09 | 2012-05-30 | 甘李药业有限公司 | 甘精胰岛素结晶的制备方法 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| JP6367115B2 (ja) | 2011-08-29 | 2018-08-01 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 2型糖尿病患者の血糖コントロールに使用する組合せ医薬 |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| US10421795B2 (en) * | 2012-12-17 | 2019-09-24 | Merck Sharp & Dohme Corp. | Process for purifying insulin and analogues thereof |
| BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
| EP3517122A1 (en) | 2013-04-03 | 2019-07-31 | Sanofi | Treatment of diabetes mellitus by long-acting formulations of insulins |
| BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
| CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| CA2954287C (en) * | 2014-07-08 | 2020-12-22 | Amphastar Pharmaceuticals, Inc. | Methods of preparing inhalable micronized insulin for pulmonary delivery |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| CN107206058A (zh) | 2014-12-12 | 2017-09-26 | 赛诺菲-安万特德国有限公司 | 甘精胰岛素/利西拉来固定比率配制剂 |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第2型糖尿病病患之治療 |
| US10322168B2 (en) | 2016-01-07 | 2019-06-18 | Amphastar Pharmaceuticals, Inc. | High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same |
| CN113773392B (zh) * | 2020-06-09 | 2023-04-07 | 宁波鲲鹏生物科技有限公司 | 一种甘精胰岛素的制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783441A (en) * | 1979-04-30 | 1988-11-08 | Hoechst Aktiengesellschaft | Aqueous protein solutions stable to denaturation |
| CA1339955C (en) | 1986-10-14 | 1998-07-14 | Richard Eugene Heiney | Process for transforming a human insulin precursor to human insulin |
| JPH0832726B2 (ja) * | 1987-06-08 | 1996-03-29 | 武田薬品工業株式会社 | ラットbFGFおよびその製造法 |
| DE3726655A1 (de) * | 1987-08-11 | 1989-02-23 | Hoechst Ag | Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten |
| IL95495A (en) * | 1989-08-29 | 1996-10-16 | Hoechst Ag | Fusion proteins their preparation and use |
| US5358857A (en) * | 1989-08-29 | 1994-10-25 | The General Hospital Corp. | Method of preparing fusion proteins |
| JP2916206B2 (ja) * | 1990-04-28 | 1999-07-05 | 帝國製薬株式会社 | 生理活性ペプチド |
| SG46612A1 (en) * | 1992-12-02 | 1998-02-20 | Hoechst Ag | Process for obtaining proinsulin in processing correctly linked cystine bridges |
| US5886154A (en) * | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
| DE19735711C2 (de) * | 1997-08-18 | 2001-04-26 | Aventis Pharma Gmbh | Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken |
| KR100253916B1 (ko) * | 1997-12-29 | 2000-05-01 | 김충환 | 사람 인슐린 전구체의 제조방법 |
| DE19947456A1 (de) * | 1999-10-02 | 2001-04-05 | Aventis Pharma Gmbh | C-Peptid zur verbesserten Herstellung von Insulin und Insulinanaloga |
| HRP20020651B1 (en) * | 2000-02-22 | 2011-01-31 | Laboratoires Serono Sa | Purified lh |
| DE10008064B4 (de) * | 2000-02-22 | 2009-07-02 | Siemens Ag | Verfahren zum Anpassen der einem Turbo-Codierer zuzuführenden Datenblöcke und entsprechende Kommunikationsvorrichtung |
-
2002
- 2002-08-01 DE DE10235168A patent/DE10235168A1/de not_active Withdrawn
-
2003
- 2003-07-18 DK DK03766211T patent/DK1527097T3/da active
- 2003-07-18 DE DE50309087T patent/DE50309087D1/de not_active Expired - Lifetime
- 2003-07-18 AT AT03766211T patent/ATE384742T1/de active
- 2003-07-18 AU AU2003254375A patent/AU2003254375B2/en not_active Ceased
- 2003-07-18 EP EP03766211A patent/EP1527097B1/de not_active Expired - Lifetime
- 2003-07-18 JP JP2004525238A patent/JP4519646B2/ja not_active Expired - Fee Related
- 2003-07-18 SI SI200331119T patent/SI1527097T1/sl unknown
- 2003-07-18 PT PT03766211T patent/PT1527097E/pt unknown
- 2003-07-18 ES ES03766211T patent/ES2297223T3/es not_active Expired - Lifetime
- 2003-07-18 MX MXPA05001042A patent/MXPA05001042A/es active IP Right Grant
- 2003-07-18 WO PCT/EP2003/007820 patent/WO2004013176A1/de not_active Ceased
- 2003-07-18 CA CA2493539A patent/CA2493539C/en not_active Expired - Fee Related
- 2003-07-18 BR BR0313131-9A patent/BR0313131A/pt active Search and Examination
- 2003-08-01 US US10/632,414 patent/US20050080000A1/en not_active Abandoned
-
2005
- 2005-01-23 IL IL166438A patent/IL166438A/en not_active IP Right Cessation
- 2005-12-15 US US11/305,508 patent/US7803763B2/en not_active Expired - Fee Related
-
2008
- 2008-02-18 CY CY20081100198T patent/CY1108046T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2493539A1 (en) | A method for purifying preproinsulin | |
| Singh et al. | Solubilization and refolding of bacterial inclusion body proteins | |
| KR100371824B1 (ko) | 정확하게연결된시스틴브릿지를갖는인슐린의수득방법 | |
| CN101068833B (zh) | 产生羧基端酰胺化肽的方法 | |
| CN1163600C (zh) | 人胰岛素原的制备方法 | |
| JP2008505985A5 (cg-RX-API-DMAC7.html) | ||
| JP2008507298A5 (cg-RX-API-DMAC7.html) | ||
| WO2013127816A1 (en) | On-column enzymatic cleavage | |
| JP2015517464A5 (cg-RX-API-DMAC7.html) | ||
| DE3850878T2 (de) | Elastase-inhibierungspolypeptide und verfahren zur herstellung durch genetische rekombination. | |
| Izumi et al. | Safe and efficient Boc‐SPPS for the synthesis of glycopeptide‐α‐thioesters | |
| RU2004100856A (ru) | Противоопухолевые и антивирусные пептиды | |
| DE602004026048D1 (de) | Verfahren zur reinigung des modifizierten hauptallergens von milben | |
| AU768443B2 (en) | Method for stabilising proteins in complex mixtures during their storage in aqueous solvents | |
| Döbeli | Polyhistidine affinity chromatography: from the idea to a method of broad applicability and the pitfalls in-between | |
| Neuner et al. | New Fmoc pseudoisocytosine monomer for the synthesis of a bis-PNA molecule by automated solid-phase Fmoc chemistry | |
| JP3105478B2 (ja) | 食用ペプチドの分画・濃縮法 | |
| CN114790473B (zh) | 一种利拉鲁肽融合蛋白在位酶切和纯化的方法 | |
| Tagliavia et al. | Regeneration and Recycling of Supports for Biological Macromolecules Purification | |
| JP3950495B2 (ja) | タンパク質の部位特異的断片化方法 | |
| JPH05502672A (ja) | ヒルジンの製造法 | |
| JP2005502865A (ja) | 可逆的方法で化学的に改質された高分子の分離法 | |
| Deng | Ultrafiltration, a useful method for isolation of intermediates in native chemical ligation exemplified with the total synthesis of Sortase AΔN59 | |
| Heinzelmann | Innovation Centre Peptide and Protein Technologies HES-SO Sion: Pioneer in an Emerging Market: biotechnet Switzerland | |
| JP2014084320A (ja) | 膜タンパク質可溶化剤 |